[Home](https://github.com/mm80843/T3.5/blob/pages/index.md) >> Class: [Risk](https://github.com/mm80843/T3.5/tree/pages/docs/Risk/index.md) >> Individual ID:PBN__Risk_7691 

# __Limitation of wbe to direct measures of viral infection such as pcr or antigen testing__

## Articles mentionning the risk

* [Daughton_wastewater_2020](https://github.com/mm80843/T3.5/blob/pages/Article/PBN__Article_450.md)

## Mitigations of this risk

* [Expansion of wbe to target endogenous biomarkers of infection, use of immunoassays, and evaluation of systemic inflammatory biomarkers](https://github.com/mm80843/T3.5/blob/pages/Mitigation/PBN__Mitigation_9572.md)

## Name of the risk

Reduced effectiveness in detecting contagious diseases in the built environment

## People affected by this risk

* [And wbe practitioners](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_46.md)
* [Public health researchers](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_2655.md)
* [Scientists](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_6426.md)

## Stakeholders who can mitigate this risk

* [Public health organizations](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_173.md)
* [Research institutions](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_413.md)

## Technologies linked to the risk

* [Biomarker detection platforms](https://github.com/mm80843/T3.5/blob/pages/Technology/PBN__Technology_9292.md)
* [Immunological assay technologies](https://github.com/mm80843/T3.5/blob/pages/Technology/PBN__Technology_9293.md)

## This Risk belongs to this RiskGroup

* [Technological risks](https://github.com/mm80843/T3.5/blob/pages/RiskGroup/PBN__RiskGroup_8.md)

## This Risk belongs to this RiskSubgroup

* [Modeling and prediction risks](https://github.com/mm80843/T3.5/blob/pages/RiskSubgroup/PBN__RiskSubgroup_47.md)

